CONCLUSIONS: Poor sleep quality is significantly associated with worse LUTS, and improvement in sleep hygiene is associated with improved LUTS. Men presenting with LUTS and older men at risk for LUTS should be counseled about optimizing sleep quality to minimize the impact of sleep on LUTS. 
INTRODUCTION AND OBJECTIVES:
While the relationship between nocturia and metabolic syndrome has been reported, that between nocturia and malnutrition has yet not been fully examined although both nocturia and malnutrition are reportedly associated with overall survival. The controlling nutritional status (CONUT) score, as calculated from serum albumin, total cholesterol concentration, and total lymphocyte count, is a practical tool for nutritional assessment. In this study, we investigated the effect of malnutrition as evaluated by the CONUT score on nocturia in males.
METHODS: This retrospective study included 340 men whose CONUT scores and other variables were recorded at the initial visit for voiding-related symptoms between 2015 and 2018 in our hospital. We assessed frequency of nocturnal voiding according to International Prostate Symptom Score. Severe nocturia was defined as voiding at night ! 3 times. Malnutrition was defined as CONUT score ! 4. Associations of severe nocturia with malnutrition and other clinical variables were examined using univariate and multivariate logistic regression analyses. The other variables collected were age, prostate-specific antigen, prostate volume, body mass index (BMI), hypertension, diabetes, insomnia, sleep apnea syndrome (SAS), cardiovascular disease, use of any medications for voiding symptoms, serum sodium concentration, C-reactive protein (CRP), and estimated glomerular filtration rate (eGFR).
RESULTS: Median age and CONUT score were 72 years and 1, respectively. Numbers of times voiding at night were 0-1/2/3/4þ in 86/ 75/84/95 men, respectively. The rates of malnutrition (CONUT score ! 4) in men with voiding at night 0-1/2/3/4-were 2%/5%/17%/20% (< 0.01), respectively. Univariate analysis demonstrated that age, BMI, hypertension, SAS, sodium concentration, CRP, eGFR and malnutrition were associated with severe nocturia. In multivariate analysis, malnutrition (odds ratio [OR] 4.0, P < 0.01) was an independent risk factor of severe nocturia in males, as were higher age (OR 2.3, P < 0.01), lower BMI (OR 1.9, P [ 0.01), the presence of SAS (OR 8.0, P < 0.01), higher CRP (OR 2.1, P < 0.01), and lower eGFR (OR 4.9, P < 0.01).
CONCLUSIONS: To our knowledge, this is the first study to demonstrate that malnutrition as evaluated by the CONUT score is associated with severe nocturia in males. 
INTRODUCTION AND OBJECTIVES: Nocturnal Polyuria (NP)
in the absence of identifiable contributory comorbidities is known as the Nocturnal Polyuria Syndrome (NPS) and is thought to be due to blunted secretion of endogenous arginine vasopressin (AVP) during the course of sleep. This study aims to determine if patients with NPS have a uniform vs. phasic nocturnal diuresis rate by comparing early (before first nocturnal void) and late (after first nocturnal void) nocturnal diuresis rates.
METHODS: A frequency-volume chart (FVC) database of 773 entries from 440 men treated at a Veterans Affairs Urology clinic was analyzed. FVCs completed by patients !18 years with !2 nocturnal voids were included. Only the first FVC was used for patients with multiple diaries. Patients with alternate causes of NP (diuretic use, sleep apnea, heart failure, edema, kidney disease, and diabetes insipidus) were excluded. Patients were divided into two cohorts by NP status using two definitions for NP: nocturnal urine production (NUP) >90 mL/h and nocturnal polyuria index (NPi) >0.33.
Standard FVC parameters were used to calculate an "early nocturnal diuresis rate" (ENDR; first nocturnal voided volume/duration of first uninterrupted sleep period), "late nocturnal diuresis rate" (LNDR; remaining nocturnal urine volume/remaining hours of sleep), and "diurnal diuresis rate" (DDR; daytime urine volume/hours awake) (Table 1a&1b) . A Wilcoxon signed-rank test was used for significance.
RESULTS: Within the NPS cohort, significant differences between ENDR and LNDR were observed for both NUP >90 mL/h (152 vs. 120 mL/h, p[0.02) and NPi >0.33 (120 vs. 91.2 mL/h, p[0.02) (Figure 1 ). Within the non-NPS cohort, no significant differences were seen between ENDR and LNDR at NUP 90 or NPi 0.33.
CONCLUSIONS: In NPS patients, there exists a unique skew in nocturnal urine production such that a disproportionately large amount of the nocturnal volume is produced in the early hours of sleep. This may provide the specific substrate for short-acting AVP replacement pharmacotherapy approved for use in patients with nocturia owing to NPS.
